Artículos de revistas
Modulatory effects of verapamil in rifampicin activity against Mycobacterium tuberculosis
Fecha
2019-02-01Registro en:
Future Microbiology. London: Future Medicine Ltd, v. 14, n. 3, p. 185-194, 2019.
1746-0913
10.2217/fmb-2018-0277
WOS:000460352400004
Autor
Universidade Estadual de Maringá (UEM)
Universidade Estadual Paulista (Unesp)
Institución
Resumen
Aim: To evaluate modulatory effect of verapamil (VP) in rifampicin (RIF) activity and its effect in efflux pumps (EPs) transcript levels in Mycobacterium tuberculosis. Materials & methods: RIF and VP minimal inhibitory concentration, combinatory effect and detection of mutations were determined in 16 isolates. EPs transcript levels were determined in four isolates by real-time PCR after exposure to drugs. Results: VP showed good combinatory effect among RIF-resistant isolates. This effect was also observed in the relative transcript levels of EPs, mainly after 72h of exposure, depending on the EP gene, genotype and the resistance profile of the isolate. Conclusion: Additional regulatory mechanisms in the EP activities, as well as, interactions with other drug-specific resistance mechanisms need further investigation in M. tuberculosis.